Flurithromycin
From Wikipedia, the free encyclopedia
 |
|
|
Flurithromycin
|
|
| Systematic (IUPAC) name | |
| (3R,4S,5S,6R,7R,9S,11R,12R,13S,14R)-6- [(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy- 6-methyloxan-2-yl]oxy-14-ethyl-9-fluoro-7,12, 13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy- 4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9, 11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C37H66FNO13 |
| Mol. mass | 751.917 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Flurithromycin is a macrolide antibiotic. It is a fluorinated derivative of erythromycin.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
